MarketPulse

BLA timeline

5 articles
GlobeNewswire Inc.GlobeNewswire Inc.··The Schall Law Firm

uniQure Faces Class Action Fraud Suit Over FDA Approval Claims

Schall Law Firm initiates securities fraud class action against uniQure ($QURE) over alleged false FDA approval statements and misleading BLA timelines.
QUREsecurities fraudclass action lawsuit
BenzingaBenzinga··The Schall Law Firm

uniQure Hit With Securities Fraud Suit Over FDA Approval Claims

Schall Law Firm seeks lead plaintiffs in class action against $QURE for alleged false statements regarding FDA approval timeline and BLA submission misrepresentations.
QUREsecurities fraudclass action lawsuit
BenzingaBenzinga··The Schall Law Firm

UniQure Faces Securities Fraud Class Action Over FDA Approval Claims

UniQure faces securities fraud lawsuit alleging false FDA approval and BLA timeline claims. Investors in stock between September-October 2025 can join class action by April 2026 deadline.
QUREsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··The Schall Law Firm

Class Action Lawsuit Filed Against uniQure Over Alleged Regulatory Misstatements

Securities fraud lawsuit filed against uniQure for allegedly making false statements about FDA approval processes and BLA submission timelines, causing investor losses.
QUREsecurities fraudclass action lawsuit
BenzingaBenzinga··Prnewswire

uniQure Securities Class Action Seeks Investors Over FDA Approval Claims

uniQure faces securities class action lawsuit over allegedly false FDA approval statements. Investors who purchased stock between September-October 2025 can join the case by April 2026.
QUREsecurities fraudclass action lawsuit